NAMI
CHRS icon

Nomura Asset Management International’s Coherus Oncology CHRS Stock Holding History

Nomura Asset Management International’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Hold
899,999
– – ﹤0.01% 1167
2026
Q1 		$1.52M Hold
899,999
– – ﹤0.01% 1029
2025
Q4 		$1.28M Buy
+899,999
New +$1.31M ﹤0.01% 1056

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Nomura Asset Management International's CHRS Position: Q2 2026 in Review

Nomura Asset Management International held its Coherus Oncology (CHRS) position steady in Q2 2026 at 899,999 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Nomura Asset Management International first reported a position in CHRS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.52M in Q1 2026. 145 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Nomura Asset Management International held 899,999 shares of Coherus Oncology worth $1.26M as of Q2 2026.
  • Nomura Asset Management International left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1167 holding.
  • Nomura Asset Management International first reported a position in Coherus Oncology in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Coherus Oncology position peaked at $1.52M in Q1 2026.
  • 145 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.